Back to User profile » Dr David Callanan
Papers published by Dr David Callanan:
Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results
Callanan D, Khurana RN, Maturi RK, Patel S, Wykoff CC, Eichenbaum D, Khanani AM, Hassan T, Badger H, Mehta S, Le G, Attar M, Seal J, Li XY
Clinical Ophthalmology 2023, 17:1367-1384
Published Date: 11 May 2023
A prospective pilot study comparing combined intravitreal ranibizumab and half-fluence photodynamic therapy with ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration
Williams PD, Callanan D, Solley W, Avery RL, Pieramici DJ, Aaberg T
Clinical Ophthalmology 2012, 6:1519-1525
Published Date: 17 September 2012
The role of difluprednate ophthalmic emulsion in clinical practice
Karim N Jamal, David G Callanan
Clinical Ophthalmology 2009, 3:381-390
Published Date: 29 June 2009
Topical nepafenac in the treatment of diabetic macular edema
David Callanan, Patrick Williams
Clinical Ophthalmology 2008, 2:689-692
Published Date: 5 December 2008